This isn't just inflation or trend, its a convergence of cost drivers - : 74% spike in $1M+ claims since 2021 - : providers are charging more : quietly adding 24% to premiums : GLP-1s and specialty drugs are reshaping budgets : demand is up, longer treatments, higher costs
pubmed.ncbi.nlm.nih.gov/30050888 Thomson RL, Spedding S, Buckley JD
GLP-1 receptor agonists are peptide therapeutics designed to mimic the action of the endogenous hormone GLP-1, an incretin, which signals the pancreas to release insulin in response to food intake
Renewals drift without visibility a tracker dashboard surfaces renewals due (7/14/30 days) and follow ups
Affordable: Provides great value for money, making it accessible to a wide range of users
Safety & Your Labs Every plan starts with baseline Labcorp bloodwork and a full review by your nurse practitioner or physician assistant, with ongoing check-ins to keep you safe